QTTB – q32 bio inc. (US:NASDAQ)
Stock Stats
News
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at Raymond James. They set a "strong-buy" rating and a $90.00 price target on the stock.
Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 [Yahoo! Finance]
Form SC 13G/A Q32 Bio Inc. Filed by: 5AM Ventures IV, L.P.
Form SC 13G Q32 Bio Inc. Filed by: BRISTOL MYERS SQUIBB CO
Form 424B3 Q32 Bio Inc.
Form 10-Q Q32 Bio Inc. For: Sep 30
Form 8-K Q32 Bio Inc. For: Nov 07
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.